Newswire (Published: Tuesday, December 12, 2017, Received: Thursday, December 7, 2017, 5:49:48 PM CST)

Word Count: 464

Reports Summarize Prostate Cancer Study Results from Temple University (Patient and Physician Factors Associated with Undisclosed Prostate Cancer Screening in a Sample of Predominantly Immigrant Black Men)

By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating in Philadelphia, Pennsylvania, by NewsRx journalists, research stated, "Medical guidelines do not recommend prostate cancer screening, particularly without informed and shared decision making. This study investigates undisclosed opportunistic screening using prostate specific antigen (PSA) testing in black immigrant and African American men."

Financial support for this research came from National Cancer Institute (see also Oncology - Prostate Cancer).

The news reporters obtained a quote from the research from Temple University, "Participants (N = 142) were insured urban men, 45- to 70-years old. Patients' reports of testing were compared with medical claims to assess undisclosed PSA testing. Most (94.4 %) men preferred to share in screening decisions, but few (46.5 %) were aware PSA testing was performed. Four factors predicted being unaware of testing: low formal education, low knowledge about prostate cancer, no intention to screen, and no physician recommendation (all p's < .05). Undisclosed PSA testing was common. Both patient and provider factors increased risk of being uninformed about prostate cancer screening."

According to the news reporters, the research concluded: "Interventions combining patient education and physician engagement in shared decision making may better align practice with current prostate cancer screening guidelines."

For more information on this research see: Patient and Physician Factors Associated with Undisclosed Prostate Cancer Screening in a Sample of Predominantly Immigrant Black Men. Journal of Immigrant and Minority Health, 2017;19(6):1343-1350. Journal of Immigrant and Minority Health can be contacted at: Springer, 233 Spring St, New York, NY 10013, USA. (Springer - www.springer.com; Journal of Immigrant and Minority Health - www.springerlink.com/content/1557-1912/)

Our news correspondents report that additional information may be obtained by contacting S.J. Lepore, Temple University, Dept. of Social & Behav Sci, Coll Public Hlth, Philadelphia, PA 19122, United States. Additional authors for this research include R.G. Nair, S.N. Davis, R.L. Wolf, C.E. Basch, N. Thomas, C. Shmukler and R. Ullman.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s10903-016-0468-1. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Keywords for this news article include: Philadelphia, Pennsylvania, United States, North and Central America, Cancer, Diagnostics and Screening, Risk and Prevention, Prostatic Neoplasms, Prostate Cancer, Oncology, Temple University.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

Temple University
National Cancer Institute

Places

Central America
North America
United States
Americas
New York
Pennsylvania
New York City
Philadelphia

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Health Sciences
            Medical Research